Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML
Clinical trial NCT05177731 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05177731
- Sponsor
- Chen Suning
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2024-02-28
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.